ArticleJournal of neurosurgery. Case lessons2025
Diffuse glioneuronal tumor in Lynch syndrome: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLynch syndrome (LS) is an autosomal dominant disorder caused by impaired DNA mismatch repair during the DNA replication process. The condition increases the risk of gastrointestinal and gynecological cancers as well as oligodendrogliomas and astrocytoma. Herein, the authors report the case of a patient with LS with an unusual tumor with features of both glial and neuronal differentiation. OBSERVATIONS: The authors present the case of a 34-year-old female who presented with headaches and was found to have a large right anterior frontal lobe mass with patchy enhancement. The patient underwent a right-sided craniotomy for tumor resection, with final pathology revealing a low-grade-appearing glioneuronal tumor. Subsequent molecular testing showed an MSH2 mutation in the tumor, and germline testing confirmed a diagnosis of LS. The patient was monitored without adjuvant treatment and subsequently had tumor progression 12 months after her index surgery. A re-resection was performed. Since tumors arising in this setting typically have an aggressive course, Ki-67 was measured, showing an increase from 2%-5% to 15%-20%. The patient has since been started on concurrent temozolomide and radiation therapy. LESSONS: Although most glioneuronal tumors typically have an indolent course relative to their diffuse glial counterparts, this case suggests that those arising in the setting of LS can have a worse prognosis. https://thejns.org/doi/10.3171/CASE24811.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.